[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"bioprosthesis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:bioprosthesis":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100561502","clinical-efficacy-and-long-term-outcomes-of-allograft-versus-stented-biological-prosthesis-for-primary-tricuspid-valve-disease-allotri-100561502",false,"NCT06591000","Clinical Efficacy and Long-term Outcomes of ALLOgraft Versus Stented Biological Prosthesis for Primary TRIcuspid Valve Disease (ALLOTRI)","Clinical Efficacy and Long-term Outcomes of Allograft Versus Stented Biological Prosthesis for Primary Tricuspid Valve Disease","Inclusion Criteria:\n\n* Patients with primary tricuspid valve disease and\u002For tricuspid bioprosthetic failure scheduled for tricuspid valve intervention.\n\n  * Intraoperative findings suggested for tricuspid valve replacement rather than repair.\n\nExclusion Criteria:\n\n* Pregnancy\n\n  * Confirmed active drug addiction\n  * Progressive HIV-infection\n  * HIV-infected patients with CD4-cells count less than 250\n  * Patients with secondary tricuspid valve pathology (left-sided valve disease)\n  * LV Ejection fraction less than 40%","ALL","18 Years","70 Years",{"count":20,"type":21},56,"ESTIMATED","OBSERVATIONAL","The aim of the study is to evaluate early safety, clinical efficacy and long-term outcomes of mitral allografts and stented biological prosthesis in tricuspid valve replacement for primary tricuspid valve diseases.",[25,26,27],"Allograft","Bioprosthesis","Tricuspid Valve Disease","RECRUITING","2024-09-07",{"date":31,"type":32},"2024-09-19","ACTUAL",{"date":34,"type":32},"2016-01-14",{"date":36,"type":21},"2025-06-14",{"name":38,"class":39},"Chelyabinsk Regional Clinical Hospital","OTHER_GOV"]